US2010190681A1PendingUtilityA1
Alpha-Amylase Mutants with Altered Properties
Est. expiryAug 1, 2020(expired)· nominal 20-yr term from priority
Y02E50/10C11D 3/38681C12N 9/2417C12Y 302/01001C12P 7/14C11D 3/386D06M 16/003C12P 19/14C11D 3/38618C12P 19/02
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to variants (mutants) of parent Termamyl-like alpha-amylases, which variant has alpha-amylase activity and exhibits altered stability, in particular at high temperatures and/or at low pH relative, and/or low Ca 2+ to the parent alpha-amylase.
Claims
exact text as granted — not AI-modified1 - 26 . (canceled)
27 . An isolated variant of a parent alpha-amylase, wherein:
(a) the variant has at least 90% sequence identity to SEQ ID NO: 8, (b) the variant comprises a substitution of the amino acid at position 239 relative to the parent alpha-amylase, using the amino acid sequence of SEQ ID NO: 8 for determining position numbering, and (c) the variant has alpha-amylase activity.
28 . The variant of claim 27 , wherein the variant has at least 95% sequence identity to SEQ ID NO: 8.
29 . The variant of claim 27 , wherein the variant has at least 97% sequence identity to SEQ ID NO: 8.
30 . The variant of claim 27 , wherein the variant has at least 99% sequence identity to SEQ ID NO: 8.
31 . The variant of claim 27 , wherein the parent alpha-amylase is a Bacillus licheniformis alpha-amylase.
32 . The variant of claim 31 , wherein the Bacillus licheniformis alpha-amylase is the amino acid sequence of SEQ ID NO: 8.
33 . The variant of claim 27 , wherein the substitution at position 239 is a substitution of serine with a different amino acid.
34 . The variant of claim 27 , wherein the variant further comprises an alteration at one or more positions selected from the group consisting of 49, 60, 104, 132, 161, 170, 176, 179, 180, 181, 183, 200, 203, 204, 207, 212, 237, 250, 280, 298, 318, 374, 385, 393, 402, 406, 427, 430, 440, 444, 447, and 482, wherein the alteration(s) are independently selected from an insertion, a deletion, or a substitution.
35 . A composition comprising the variant of claim 27 and (i) another alpha-amylase; or (ii) one or more enzymes selected from the group consisting of glucoamylase, phytase, and pullulanase.
36 . An isolated variant of a parent alpha-amylase, wherein:
(a) the variant has an amino acid sequence with 1-15 alteration(s) relative to the parent alpha-amylase, wherein (i) the 1-15 alteration(s) are independently selected from an insertion, a deletion, or a substitution, and (ii) the 1-15 alteration(s) include a substitution of the amino acid at position 239, and (b) the parent alpha-amylase has at least 90% sequence identity to SEQ ID NO: 8, and (c) the amino acid sequence of SEQ ID NO: 8 is used for determining position numbering; and (d) the variant has alpha-amylase activity.
37 . The variant of claim 36 , wherein the alteration(s) are substitution(s).
38 . The variant of claim 36 , wherein the variant has 1 alteration relative to the parent alpha-amylase which is the substitution of the amino acid at position 239.
39 . The variant of claim 36 , wherein the substitution at position 239 is a substitution of serine with a different amino acid.
40 . The variant of claim 36 , wherein the parent alpha-amylase has at least 95% sequence identity to SEQ ID NO: 8.
41 . The variant of claim 36 , wherein the parent alpha-amylase has at least 99% sequence identity to SEQ ID NO: 8.
42 . The variant of claim 36 , wherein one or more alteration(s) are at a position selected from the group consisting of 49, 60, 104, 132, 161, 170, 176, 179, 180, 181, 183, 200, 203, 204, 207, 212, 237, 250, 280, 298, 318, 374, 385, 393, 402, 406, 427, 430, 440, 444, 447, and 482.
43 . A composition comprising the variant of claim 36 and (i) another alpha-amylase or (i) one or more enzymes selected from the group consisting of glucoamylase, phytase.
44 . An isolated variant of a Bacillus licheniformis alpha-amylase, wherein the variant consists of a substitution of the amino acid at position 239 with a different amino acid, using the amino acid sequence of SEQ ID NO: 8 for determining position numbering.
45 . The variant of claim 44 , wherein the substitution at position 239 is a substitution of serine.
46 . The variant of claim 44 , wherein the Bacillus stearothermophilus alpha-amylase is the amino acid sequence of SEQ ID NO: 6.Join the waitlist — get patent alerts
Track US2010190681A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.